Zhaoli Tan
Beijing, 100071, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
miR-196b strictly regulates and reliably predicts the response to cetuximab in colorectal cancer.
Journal: Cellular & molecular biology letters
Published: January 08, 2025
Single-cell sequencing analysis reveals cetuximab resistance mechanism and salvage strategy in colorectal cancer.
Journal: Clinical and translational medicine
Published: October 04, 2024
Hyperprogressive disease during PD-1 blockade in patients with advanced pancreatic cancer.
Journal: Human vaccines & immunotherapeutics
Published: September 07, 2023
A composite indicator of derived neutrophil-lymphocyte ratio and lactate dehydrogenase correlates with outcomes in pancreatic carcinoma patients treated with PD-1 inhibitors.
Journal: Frontiers in oncology
Published: May 24, 2022
Assessment of PD-L1 Expression on Circulating Tumor Cells for Predicting Clinical Outcomes in Patients with Cancer Receiving PD-1/PD-L1 Blockade Therapies.
Journal: The oncologist
Published: June 13, 2020
PRSS contributes to cetuximab resistance in colorectal cancer.
Journal: Science advances
Published: April 02, 2019
Transcriptome Alterations in Liver Metastases of Colorectal Cancer After Acquired Resistance to Cetuximab.
Journal: Cancer genomics & proteomics
Published: February 17, 2019
A region-resolved mucosa proteome of the human stomach.
Journal: Nature communications
Published: May 18, 2018
MicroRNA Let-7b inhibits keratinocyte migration in cutaneous wound healing by targeting IGF2BP2.
Journal: Experimental dermatology
Published: August 02, 2016
Lineage tracing reveals conversion of liver sinusoidal endothelial cells into hepatocytes.
Journal: Development, growth & differentiation
Published: May 19, 2016
DNA in serum extracellular vesicles is stable under different storage conditions.
Journal: BMC cancer
Published: April 20, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026